216 related articles for article (PubMed ID: 34691060)
1. Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling.
Kirby D; Parmar B; Fathi S; Marwah S; Nayak CR; Cherepanov V; MacParland S; Feld JJ; Altan-Bonnet G; Zilman A
Front Immunol; 2021; 12():748423. PubMed ID: 34691060
[TBL] [Abstract][Full Text] [Related]
2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
3. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43.
Sarasin-Filipowicz M; Wang X; Yan M; Duong FH; Poli V; Hilton DJ; Zhang DE; Heim MH
Mol Cell Biol; 2009 Sep; 29(17):4841-51. PubMed ID: 19564419
[TBL] [Abstract][Full Text] [Related]
4. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)-induced gene expression
Blumer T; Coto-Llerena M; Duong FHT; Heim MH
J Biol Chem; 2017 Oct; 292(43):17928-17938. PubMed ID: 28900038
[TBL] [Abstract][Full Text] [Related]
6. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response.
François-Newton V; Magno de Freitas Almeida G; Payelle-Brogard B; Monneron D; Pichard-Garcia L; Piehler J; Pellegrini S; Uzé G
PLoS One; 2011; 6(7):e22200. PubMed ID: 21779393
[TBL] [Abstract][Full Text] [Related]
7. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
8. Receptor density is key to the alpha2/beta interferon differential activities.
Moraga I; Harari D; Schreiber G; Uzé G; Pellegrini S
Mol Cell Biol; 2009 Sep; 29(17):4778-87. PubMed ID: 19564411
[TBL] [Abstract][Full Text] [Related]
9. Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor.
Platanias LC; Uddin S; Domanski P; Colamonici OR
J Biol Chem; 1996 Sep; 271(39):23630-3. PubMed ID: 8798579
[TBL] [Abstract][Full Text] [Related]
10. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha beta secreted during infection is necessary but not sufficient for negative feedback regulation of IFN-alpha beta signaling by Mycobacterium tuberculosis.
Prabhakar S; Qiao Y; Canova A; Tse DB; Pine R
J Immunol; 2005 Jan; 174(2):1003-12. PubMed ID: 15634924
[TBL] [Abstract][Full Text] [Related]
12. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
13. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response.
Kundu K; Dutta K; Nazmi A; Basu A
Cell Immunol; 2013; 285(1-2):100-10. PubMed ID: 24140964
[TBL] [Abstract][Full Text] [Related]
15. Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation.
Hayashi T; Kaneda T; Toyama Y; Kumegawa M; Hakeda Y
J Biol Chem; 2002 Aug; 277(31):27880-6. PubMed ID: 12023971
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis for differential type I interferon signaling.
Schreiber G
J Biol Chem; 2017 May; 292(18):7285-7294. PubMed ID: 28289098
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
[TBL] [Abstract][Full Text] [Related]
18. Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.
Gingras S; Parganas E; de Pauw A; Ihle JN; Murray PJ
J Biol Chem; 2004 Dec; 279(52):54702-7. PubMed ID: 15491990
[TBL] [Abstract][Full Text] [Related]
19. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.
Takaoka A; Mitani Y; Suemori H; Sato M; Yokochi T; Noguchi S; Tanaka N; Taniguchi T
Science; 2000 Jun; 288(5475):2357-60. PubMed ID: 10875919
[TBL] [Abstract][Full Text] [Related]
20. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.
Malakhova OA; Kim KI; Luo JK; Zou W; Kumar KG; Fuchs SY; Shuai K; Zhang DE
EMBO J; 2006 Jun; 25(11):2358-67. PubMed ID: 16710296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
